COSMOS PHARMACEUTICAL CORPORATION |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,390 JPY | -0.79% |
|
-0.28% | -11.64% |
| 04-12 | Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months | MT |
| 01-12 | Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores | MT |
Evolution of the average Target Price on COSMOS Pharmaceutical Corporation
Price target over the last 5 years
History of analyst recommendation changes
bd745d4eebda4.LP_BR7_eVeCkOoNzwADnlDmQCAvXgcYErAdgtNclrs0.YKz4JdzubZD-AtcxhG-BxXfbcluh87FJw140_pVw95htx5Qs-OoNg_x11g~894bb85671519c93b26532bef7e7b36c
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
14,390
JPY
Average target price
16,620
JPY
Spread / Average Target
+15.50%
High Price Target
20,000
JPY
Spread / Highest target
+38.99%
Low Price Target
13,100
JPY
Spread / Lowest Target
-8.96%
Consensus detail
Consensus revision (last 18 months)
Analysts covering COSMOS Pharmaceutical Corporation
| UBS |
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
- Stock Market
- Equities
- 3349 Stock
- Consensus COSMOS Pharmaceutical Corporation
